FDA.reportPublic FDA data

Application 214339

Type
ANDA
Sponsor
ASPIRO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION1%NoNo
002LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION2%NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
31722-117Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-117Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-117Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-117Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-118Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-118Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-118Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent
31722-118Lidocaine HydrochlorideLidocaine HydrochlorideCamber Pharmaceuticals, Inc.ANDACurrent